COMMUNIQUÉS West-GlobeNewswire

Medifirst Solutions Announces the Launch of a New Division Focusing on Specialty Prescription Billing and Pharmacy Solutions

12/04/2018 - 16:01

FREEHOLD, NJ, April 12, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]

C-RAD Web Presentation Interim Report Q1 2018

12/04/2018 - 16:00

Presentation of the report for the first quarter of the fiscal year 2018: Date: Thursday April 26, 2018 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Interim Report Q1 2018 Procedure: Please register online [...]

Matrix Medical Network announces the appointment of Heidi Cannon as Senior Vice President, Account Management

12/04/2018 - 16:00

SCOTTSDALE, Ariz., April 12, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix), a leading population health provider of in-home and mobile health services, has announced that Heidi Cannon has joined the company [...]

Nymox Announces $16.25 Million Equity Financing With Qualified Long-Term Investors

12/04/2018 - 15:45

HASBROUCK HEIGHTS, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to announce today that the Company has successfully secured $16.25 million in new equity capital [...]

ICC Labs Enters Into Term Sheet for Export of Cannabidiol to Sundial in Canada

12/04/2018 - 15:39

Highlights: Term sheet paves the way for the distribution of ICC Labs’ medicinal cannabidiol (CBD) products through Sundial’s licensed dealer partners in Canada Sundial to purchase up to 250,000 grams per year of pure [...]

Reduction of common stock

12/04/2018 - 15:34

Please read the full announcement in the attached PDF Attachment 2018_13_Reduction_of_common_stock_EN

Fluidigm Releases CFTR Next-Generation Sequencing Library Prep Assay for Use With the Juno System

12/04/2018 - 15:29

SOUTH SAN FRANCISCO, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced the introduction of the Advanta™ CFTR NGS Library Prep Assay, a highly efficient and scalable next- [...]

PolarityTE Announces Pricing of Public Offering of Common Stock

12/04/2018 - 15:15

SALT LAKE CITY, April 12, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]

Hitachi High-Tech Participates in OmniSeq Series B and Secures Japanese Distribution Rights

12/04/2018 - 15:00

BUFFALO, N.Y., April 12, 2018 (GLOBE NEWSWIRE) -- OmniSeq ® , a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, announced today Hitachi High-Technologies Corporation (TYO:8036) (Hitachi [...]

Press Release: Chief Executive Officer Yrjö Närhinen to Terveystalo's Annual General Meeting of Shareholders 2018: It is now time to develop the Finnish healthcare system further

12/04/2018 - 14:51

In his address to the Annual General Meeting of Shareholders, Chief Executive Officer Yrjö Närhinen highlighted the ever-important role of private healthcare services in the Finnish society and healthcare system. Now it [...]

Targovax strengthens Board of Directors with the appointment of Catherine Wheeler

12/04/2018 - 14:48

Oslo, Norway, 12 April 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces the appointment of Catherine Wheeler MD to the [...]

Imagin Medical Closing Private Placement

12/04/2018 - 14:30

VANCOUVER, British Columbia, April 12, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt: DPD2 ) (STUT:DPD2) (the “Company”) announced today that, further to its press release of April 3, [...]

GTX Corp to Present at the Equities Spring 2018 Investor Wealth Conference

12/04/2018 - 14:15

LOS ANGELES, April 12, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced that it [...]

Organovo Presents Data on Modeling Liver Disease Using 3D Bioprinted Human Liver Tissue at The International Liver Congress™

12/04/2018 - 14:05

SAN DIEGO, April 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today presented data on modeling non-alcoholic fatty liver disease (“NAFLD”) using its 3D bioprinted human liver tissues [...]

Jounce Therapeutics to Present Nonclinical Translational Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting

12/04/2018 - 14:00

CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

Impact Health is the First to Implement eTrueNorth’s Technology to Facilitate Quality Control Monitoring

12/04/2018 - 14:00

eTrueNorth’s eQC POCT™ software empowers end-to-end biometric result traceability to the individual point-of-care device and reagent lot number DALLAS, April 12, 2018 (GLOBE NEWSWIRE) -- e TrueNorth, the U.S.-based [...]

International Liver Congress™ 2018 Symposium Highlights Celsion’s ThermoDox® in Treatment of Primary Liver Cancer

12/04/2018 - 14:00

LAWRENCEVILLE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced a presentation and discussion of ThermoDox®, its proprietary heat- [...]

Adaptimmune Announces Changes to Board of Directors

12/04/2018 - 14:00

PHILADELPHIA, Pa. and OXFORD, U.K., April 12, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, today announced that, in a planned transition, John Furey [...]

Spero Therapeutics Appoints Ian A. Critchley, Ph.D., as Head of Clinical Microbiology

12/04/2018 - 14:00

Building organization to support SPR994 in Phase 3 and beyond, and robust pipeline CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO ), a multi-asset clinical-stage [...]